Author

Janai R. Carr

University of California Davis Medical CenterORCID 0000-0002-2074-4643Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Clifford G. TepperiD· 1 shared Edmond F. O’DonnelliD· 1 shared Jessica BergonioiD· 1 shared Maria MuñoziD· 1 shared Robert Lor RandalliD· 1 shared Ryan R. DavisiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

6 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Clifford G. TepperORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Genetic and Epigenetic Characterization of Sarcoma Stem Cells Across Subtypes Identifies EZH2 as a Therapeutic Target

Edmond F. O’Donnell, Maria Muñoz, Ryan R. Davis, Jessica Bergonio, Robert Lor Randall, Clifford G. Tepper, Janai R. Carr

The paper identifies EZH2 as a therapeutic target in sarcoma stem cells (STS-CSCs) across subtypes, showing that targeting EZH2 reduces CSC populations and restores chemosensitivity in resistant cell lines.

npj Precision Oncology · Jan 9, 2025Peer-reviewedCancer Biology